Beruflich Dokumente
Kultur Dokumente
Definition of Pain
An unpleasant sensory and emotional experience associated with actual and potential tissue damage or described in terms of such damage
IASP Subcommitee on Taxonomy. Pain 1980; 8:249-252
Definition of Pain
Nociceptors
1. A-delta fibers myelinated 2-30 m/sec (1st pain) 2. C-fibers unmyelinated <2 m/sec (2nd pain)
Spinothalamic
Spinomesencephalic
Spinoreticular
Pain Pathway
PAG / RAS
Descending inhibitory fibres
PAIN
Sensory cortex
Thalamus
Ascending ST tracts
Effects of Pain
I. Physiological
- Cardiovascular System - Respiratory system - Gastrointestinal system - Genitourinary system - Central Nervous System - Endocrine system
Cardiovascular System
Increased Heart Rate Increased Blood Pressure
increased myocardial work load myocardial oxygen consumption increased risk of myocardial ischaemia
Respiratory system
Inhibition of normal respiration (unable to take deep breaths)
Atelectasis Hypoxia
Inability to cough
Retention of secretions Increased risk of lung infection / pneumonia
Gastrointestinal System
Increased sympathetic and reduced parasympathetic activity
Reduced smooth muscle + sphincter tone Reduced gut motility Ileus, nausea + vomiting Impedes early feeding
Genitourinary System
Increased sympathetic and reduced parasympathetic tone
reduced smooth muscle + sphincter tone urinary retention
Musculoskeletal system
Prevent mobilisation & increases muscle tone Increased risk of deep vein thrombosis
Endocrine System
Stimulation of stress response
Increased sympathoadrenal activation Metabolic response to stress Hyperglycemia Catabolic state
Immunosuppression
risk of infection
5th Vital Sign: Doctors training module: Pain Physiology
Psychological
Anxiety Agitation
poor sleep uncooperative patient
Economic
Delayed ambulation and feeding Increased postoperative complications Delayed recovery Prolonged hospital stay Increased cost
Spectrum of Pain
ACUTE PAIN
Healing
NO PAIN
Insidious onset
CHRONIC PAIN
post-surgical syndromes / cancer
ACUTE PAIN
5th Vital Sign: Doctors training module: Pain Physiology
CHRONIC PAIN
Chronic Pain
Onset may be insiduous. Pain persists despite tissue healing. Not a warning signal of damage : a false alarm Severity not correlated with damage.Good days and Bad days. CNS may be dysfunctional chronic pain is a disease Often associated with depression, anger, fear, social withdrawal, etc
Surgery, fracture, burns, myocardial infarct, labour and childbirth, inflammatory conditions e.g. abscess
Chronic headache, back pain, chronic pelvic / abd pain, cancer pain, neuropathic pain PHN, DPN, post stroke pain, etc
Assessment of Pain
Pain is both a physical and a psychological
phenomenon
The pain experience is subjective Meaningful evaluation and successful treatment of a patient with pain requires quantification of the patients pain
Pain as the 5th Vital Sign Guidelines for Doctors (Management of Adult Patients)
Pain as the 5th Vital Sign Guidelines for Doctors (Management of Paediatric Patients)
A : Aggravating factors
What makes the pain worse?
I : Intensity
How bad is the pain?
TELL ME ABOUT YOUR PAIN P Place A Aggravating factors I Intensity Where is your pain? What makes the pain worse? If 0 is no pain and 10 is the worst pain imaginable: What is your pain score now? What is the worst level of pain (score) you experience in a day? What is the least pain (score) you experience in a day? Describe your pain e.g. aching, throbbing, burning, shooting, stabbing, sharp, dull, deep, pressure, etc What makes the pain better?
NRS/
FLACC Scale
Analgesics
Non Opioids
Paracetamol NSAIDS COX 2 inhibitors
Opioids
Weak Strong
NSAID Diclofenac Tablet 50mg & 25mg, Suppositories 12.5mg, 25mg, (50mg & 100mg)* Gel Capsule 250mg Tablet 200mg & 400mg* Tablet 250mg, 550mg Capsule 100mg *, Injection 100mg, Patch 30mg, Gel Injection 30mg/ml Tab 7.5mg Oral: 50mg tds, Sup: 50mg-100mg stat Topical: PRN 250 mg 500mg tds 200 mg 400 mg tds 500mg-550 mg bd Oral: 100mg daily, IV: 100mg bd Patch: 30mg - 60mg bd, Topical: PRN 10mg - 20 mg bd max 3 days Daily or bd
Mefenamic Acid (Ponstan) Ibuprofen ( Brufen) Naproxen (Naprosyn, Synflex) Ketoprofen (Orudis, Oruvail)
DRUG
COX 2 inhibitors Celecoxib Etoricoxib Parecoxib WEAK OPIOID Tramadol Dihydrocodeine (DF118)
FORMULATION AVAILABLE
DOSAGE
200 mg bd (max 1 week) 120 mg daily (max 1 week) 40 mg bd ( 20 mg bd for elderly) max for 2 days 50mg -100mg tds or qid (max 400mg/day) 30mg-60mg qid (max 360mg/day)
DRUG
STRONG OPIOID
FORMULATION AVAILABLE
DOSAGE
Nalbuphine (Nubain)
Morphine
Injection 10mg/ml
Fentanyl
Pethidine
Oxycodone (Oxycontin)
Stat dose only: 10mg (equivalent to Morphine 10mg). Do not use in patients on regular Morphine/ Pethidine/ Fentanyl. Tablet SR 10mg,30mg SR and Aqueous to be used for cancer pain Aqueous 10mg / 5ml IV and Subcut : Injection 10 mg/ml, < 65yrs : 5mg -10mg 3-4hrly > 65yrs : 2.5mg -5mg 3-4hrly Reduce dose in renal and hepatic impairment Injection 50 mcg/ml, IV only to be prescribed by APS team. Patch 25 mcg, 50 mcg Patch to be used in cancer pain; NOT in Acute Pain Injection IV and Subcut : 50mg/ml,100mg/2ml < 65yrs : 50mg -100mg 3-4hrly > 65yrs : 25mg -50mg 3-4hrly Reduce dose in renal and hepatic impairment. Use not encouraged because of Norpethidine toxicity and high risk of addiction. Tablet SR 10mg & Mainly used for cancer pain 20mg
SEVERE 7-10 Regular Higher dose of weak opioid Or IV/SC Morphine 510mg 4 hrly OR Aqueous morphine 10-20 mg PCM 1gm QID oral / rectal NSAID / COX2 inhibitor PRN IV/SC Morphine 5-10mg OR Aqueous morphine *Oral or SC Morphine may be safely given at hourly intervals
UNCONTROLLED
MODERATE 4-6 Regular Weak Opioid PCM 1gm QID oral NSAID / COX2 inhibitor PRN Additional weak opioid
MILD 0-3 Regular No medicati on or PCM 1gm 6hrly PRN PCM &/or NSAID / COX2 inhibitor
3. Other Methods i. Nerve & Nerve Plexus Blocks ii. Transcutaneous Electrical Nerve Stimulation (TENS) iii. Rectal NSAIDS 4. Multi-modal Concepts
EPIDURAL ANALGESIA
- BUPIVACAINE
OPIODS ALONE
- FENTANYL
- MORPHINE
MIXTURES (COCKTAIL)
- FENTANYL + BUPIVACAINE